论文部分内容阅读
近年来,我们采用头孢哌酮钠与舒巴坦钠治疗肺部感染39例,疗效满意,报告如下。1资料与方法1.1一般资料入选标准:①年龄18岁以上,性别不限;②有发热、咳嗽症状,肺部出现实质体征或闻及湿哕音,胸部X线出现新的浸润阴影,并排除其他原因的肺浸润或经细菌学证实诊断;③病情严重程度按美国胸科学会(ATS)1993年关于重度肺部感染的界定。本组39例,男26例,女13例;年龄20-75岁。病重范围为一叶或多叶肺炎20例,合并慢性阻塞性肺疾病(COPD)19例,均有咳嗽或咳痰及不同程度的呼吸困难和发热症状,其中白细胞、中性粒细胞升高36例。
In recent years, we use cefoperazone sodium and sulbactam sodium in 39 cases of lung infection, with satisfactory results, the report is as follows. 1 Materials and Methods 1.1 General Information Inclusion criteria: ① age 18 years of age or older, gender is not limited; ② have fever, cough, lung signs or wet real signs of wet sound, chest X-ray showed a new infiltration shadow, and excluded Other causes of pulmonary infiltrates or confirmed by bacteriological diagnosis; the severity of the disease according to the American Thoracic Society (ATS) in 1993 on the definition of severe pulmonary infection. The group of 39 cases, 26 males and 13 females; aged 20-75 years. Twenty patients with one or more leaf pneumonia and 19 patients with chronic obstructive pulmonary disease (COPD), all had cough or sputum and various degrees of dyspnea and fever symptoms, including leukocyte and neutrophil 36 cases.